These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10935508)

  • 1. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.
    Yi S; Tsao MS
    Neoplasia; 2000; 2(3):226-34. PubMed ID: 10935508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
    Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
    Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
    To C; Seiden I; Liu N; Wigle D; Tsao MS
    Exp Cell Res; 2002 Feb; 273(1):45-53. PubMed ID: 11795945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
    Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
    Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
    Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
    Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
    J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.
    Leibowitz-Amit R; Tsarfaty G; Abargil Y; Yerushalmi GM; Horev J; Tsarfaty I
    Cancer Res; 2006 Sep; 66(17):8687-97. PubMed ID: 16951184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla.
    Kajihara T; Ohnishi T; Arakaki N; Semba I; Daikuhara Y
    Arch Oral Biol; 1999 Feb; 44(2):135-47. PubMed ID: 10206332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.
    Tokunou M; Niki T; Eguchi K; Iba S; Tsuda H; Yamada T; Matsuno Y; Kondo H; Saitoh Y; Imamura H; Hirohashi S
    Am J Pathol; 2001 Apr; 158(4):1451-63. PubMed ID: 11290563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
    Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
    Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
    Rygaard K; Nakamura T; Spang-Thomsen M
    Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C; Luddy C; Abounader R; Lal B; Laterra J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.
    Onitsuka T; Uramoto H; Ono K; Takenoyama M; Hanagiri T; Oyama T; Izumi H; Kohno K; Yasumoto K
    J Thorac Oncol; 2010 May; 5(5):591-6. PubMed ID: 20150826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine stimulation of motility in SBC-5 human lung carcinoma cells by a two-kringle variant of HGF.
    Itakura Y; Yamamoto T; Matsumoto K; Nakamura T
    Cancer Lett; 1994 Aug; 83(1-2):235-43. PubMed ID: 8062221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.